Listed Japanese companies ranked by total assets.
81 listed companies (total ¥41.82T)
| # | Company | Total assets | Net assets | Revenue | Net income |
|---|---|---|---|---|---|
| 1 | Takeda Pharmaceutical Company Limited | ¥15.51T | ¥7.43T | ¥4.51T | −¥152B |
| 2 | Otsuka Holdings Co., Ltd. | ¥4.20T | ¥3.03T | ¥2.47T | ¥363B |
| 3 | Daiichi Sankyo Company, Limited | ¥4.00T | ¥1.68T | ¥2.12T | ¥280B |
| 4 | Astellas Pharma Inc. | ¥3.57T | ¥1.83T | ¥2.14T | ¥292B |
| 5 | Shionogi & Co.,Ltd. | ¥2.58T | ¥1.69T | ¥500B | ¥205B |
| 6 | Chugai Pharmaceutical Co., Ltd. | ¥2.47T | ¥2.03T | ¥1.26T | ¥434B |
| 7 | Eisai Co., Ltd. | ¥1.45T | ¥899B | ¥825B | ¥38.6B |
| 8 | Kyowa Kirin Co.,Ltd. | ¥1.11T | ¥893B | ¥497B | ¥67.0B |
| 9 | ONO Pharmaceutical Co., Ltd. | ¥1.11T | ¥851B | ¥516B | ¥69.8B |
| 10 | Sumitomo Pharma Co., Ltd. | ¥805B | ¥292B | ¥453B | ¥107B |
| 11 | Tsumura & Co. | ¥593B | ¥372B | ¥193B | ¥28.1B |
| 12 | Rohto Pharmaceutical Co., Ltd. | ¥486B | ¥320B | ¥344B | ¥34.2B |
| 13 | TOWA Pharmaceutical Co., Ltd. | ¥475B | ¥178B | ¥274B | ¥5.2B |
| 14 | Santen Pharmaceutical Co., Ltd. | ¥423B | ¥297B | ¥292B | ¥37.4B |
| 15 | SAWAI GROUP HOLDINGS Co., Ltd. | ¥360B | ¥179B | ¥202B | ¥10.4B |
| 16 | Nippon Shinyaku Co.,Ltd. | ¥346B | ¥292B | ¥171B | ¥29.7B |
| 17 | Kissei Pharmaceutical Co., Ltd. | ¥275B | ¥232B | ¥97.4B | ¥13.8B |
| 18 | KYORIN Pharmaceutical Co., Ltd. | ¥195B | ¥142B | ¥126B | ¥3.4B |
| 19 | Mochida Pharmaceutical Co.,Ltd. | ¥183B | ¥140B | ¥117B | ¥7.9B |
| 20 | Zeria Pharmceutical Co., Ltd. | ¥180B | ¥109B | ¥89.2B | ¥8.5B |
| 21 | Kaken Pharmaceutial Co., Ltd. | ¥178B | ¥148B | ¥76.9B | ¥2.1B |
| 22 | Nxera Pharma Co., Ltd. | ¥135B | ¥61.0B | ¥29.6B | −¥12.5B |
| 23 | ASKA Pharmaceutical Holdings CO., Ltd. | ¥112B | ¥76.8B | ¥71.1B | ¥5.4B |
| 24 | JCR Pharmaceuticals Co.,Ltd. | ¥109B | ¥47.4B | ¥40.3B | ¥2.2B |
| 25 | Fuji Pharma Co.,Ltd. | ¥93.4B | ¥46.9B | ¥51.7B | ¥3.0B |
| 26 | Fuso Pharmaceutical Industries,Ltd. | ¥90.3B | ¥35.1B | ¥62.3B | ¥2.0B |
| 27 | Seikagaku Corporation | ¥86.3B | ¥75.3B | ¥36.6B | ¥1.5B |
| 28 | GNI Group Ltd. | ¥83.8B | ¥50.3B | ¥26.8B | −¥4.2B |
| 29 | PeptiDream Inc. | ¥77.0B | ¥51.5B | ¥18.5B | −¥3.7B |
| 30 | Daito Pharmaceutical Co., Ltd. | ¥73.3B | ¥52.9B | ¥50.6B | ¥3.2B |
| 31 | Eiken Chemical Co., Ltd. | ¥62.7B | ¥44.0B | ¥41.9B | ¥3.7B |
| 32 | Nippon Chemiphar Co., Ltd. | ¥50.0B | ¥19.5B | ¥33.1B | ¥198M |
| 33 | TAUNS Laboratories, Inc. | ¥44.6B | ¥19.4B | ¥14.4B | ¥5.5B |
| 34 | KOA Shoji Holdings Co., Ltd. | ¥39.5B | ¥31.2B | ¥24.7B | ¥3.7B |
| 35 | YUKI Gosei Kogyo Co., Ltd. | ¥25.7B | ¥13.5B | ¥15.4B | ¥313M |
| 36 | Mizuho MEDY Co., Ltd. | ¥22.4B | ¥18.7B | ¥11.3B | ¥3.4B |
| 37 | Morishita Jintan Co., Ltd. | ¥18.6B | ¥13.0B | ¥12.7B | ¥628M |
| 38 | Healios K.K. | ¥17.1B | ¥4.9B | ¥104M | −¥2.2B |
| 39 | Wakamoto Pharmaceutical Co., Ltd. | ¥16.5B | ¥12.0B | ¥9.9B | ¥227M |
| 40 | SanBio Company Limited | ¥15.6B | ¥13.6B | — | −¥3.8B |
| 41 | Taiko Pharmaceutical Co., Ltd. | ¥12.3B | ¥8.5B | ¥6.4B | ¥923M |
| 42 | RaQualia Pharma Inc. | ¥10.5B | ¥6.9B | — | ¥273M |
| 43 | Kohjin Bio Co., Ltd. | ¥8.9B | ¥5.9B | ¥4.9B | ¥251M |
| 44 | StemCell Institute Inc. | ¥8.1B | ¥3.1B | ¥2.8B | ¥156M |
| 45 | Ｈｅａｒｔｓｅｅｄ株式会社 | ¥7.7B | ¥7.2B | ¥3.0B | ¥191M |
| 46 | Muromachi Chemicals Inc. | ¥6.4B | ¥2.6B | ¥7.8B | ¥163M |
| 47 | Kidswell Bio Corporation | ¥6.1B | ¥1.7B | ¥6.6B | −¥414M |
| 48 | StemRIM Inc. | ¥5.9B | ¥5.7B | — | −¥1.9B |
| 49 | Nano Holdings, Inc. | ¥5.9B | ¥3.6B | ¥174M | −¥944M |
| 50 | AnGes, Inc. | ¥5.4B | ¥3.1B | — | −¥5.1B |
| 51 | Chukyoiyakuhin Co., Ltd. | ¥5.3B | ¥2.6B | ¥6.6B | ¥83.6M |
| 52 | Cuorips Inc. | ¥5.1B | ¥4.8B | ¥212M | −¥1.0B |
| 53 | イノバセル株式会社 | ¥5.1B | −¥630M | — | −¥2.9B |
| 54 | J-Pharma Co.,Ltd. | ¥4.8B | ¥4.4B | — | −¥2.5B |
| 55 | Oncolys BioPharma Inc. | ¥4.6B | ¥4.0B | ¥28.5M | −¥2.1B |
| 56 | ステラファーマ株式会社 | ¥4.5B | ¥2.4B | ¥323M | −¥781M |
| 57 | 株式会社サイフューズ | ¥4.3B | ¥2.8B | ¥231M | −¥764M |
| 58 | ノイルイミューン・バイオテック株式会社 | ¥4.0B | ¥3.9B | — | −¥794M |
| 59 | SymBio Pharmaceuticals Limited | ¥3.9B | ¥1.3B | ¥1.3B | −¥4.8B |
| 60 | Renascience Inc. | ¥3.5B | ¥3.3B | — | −¥301M |
| 61 | 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ | ¥3.1B | ¥2.7B | ¥677M | −¥834M |
| 62 | RIBOMIC Inc. | ¥3.0B | ¥2.8B | ¥3.0M | −¥1.1B |
| 63 | Modalis Therapeutics Corporation | ¥3.0B | ¥2.8B | — | −¥2.2B |
| 64 | K Pharma,Inc. | ¥2.9B | ¥1.3B | — | −¥993M |
| 65 | TMS Co., Ltd | ¥2.9B | ¥2.8B | — | −¥716M |
| 66 | Chordia Therapeutics,Inc | ¥2.7B | ¥2.4B | — | −¥1.8B |
| 67 | BrightPath Biotherapeutics Co., Ltd. | ¥2.6B | ¥2.4B | ¥84,000 | −¥1.3B |
| 68 | OncoTherapy Science, Inc. | ¥2.4B | ¥2.1B | — | −¥911M |
| 69 | D.Western Therapeutics Institute, Inc. | ¥2.2B | ¥1.4B | ¥388M | −¥632M |
| 70 | 株式会社メドレックス | ¥2.2B | ¥2.0B | ¥128M | −¥937M |
| 71 | Immuno-Biological Laboratories Co., Ltd. | ¥2.2B | ¥1.8B | ¥1.0B | ¥329M |
| 72 | ソレイジア・ファーマ株式会社 | ¥2.1B | ¥1.8B | ¥429M | −¥876M |
| 73 | Kringle Pharma,Inc. | ¥2.1B | ¥1.3B | ¥72.2M | −¥916M |
| 74 | 株式会社ファンペップ | ¥2.0B | ¥1.5B | — | −¥1.9B |
| 75 | Kubota Pharmaceutical Holdings Co., Ltd. | ¥2.0B | ¥1.8B | ¥21.3M | −¥676M |
| 76 | 株式会社Ｖｅｒｉｔａｓ Ｉｎ Ｓｉｌｉｃｏ | ¥1.9B | ¥1.8B | — | −¥426M |
| 77 | CanBas Co.,Ltd. | ¥1.8B | ¥1.6B | — | −¥1.3B |
| 78 | Chiome Bioscience Inc. | ¥1.7B | ¥1.1B | ¥593M | −¥983M |
| 79 | Perseus Proteomics Inc. | ¥1.6B | ¥1.2B | ¥136M | −¥718M |
| 80 | Carna Biosciences, Inc. | ¥1.2B | ¥309M | ¥579M | −¥2.2B |
| 81 | Delta-Fly Pharma, Inc. | ¥247M | ¥34.0M | — | −¥1.6B |
From the latest annual securities reports filed with EDINET. Fiscal years differ by company.